FDA Investigator Yan Wang
Yan Wang has inspections in 2 countries as of 27 Jul 2023. Yan Wang has collaborated with a combined 489 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
27 Jul 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
India
Co-Investigator(s):
Aditi S Thakur,
Alberto A Viciedo,
Charles Yuanchia Kuo, PhD,
Cynthia Jim, CSO,
Dawn L Wydner,
Edmund F Mrak, Jr,
Guerlain Ulysse,
Jose O Hernandez,
Jose Ohernandez Guzman,
Kathleen M Jordan,
Ko U Min,
Leiyun Boone, PhD,
Marlene G Swider,
Michael R Klapal,
Nailing Zhang,
Patricia Fhughes Troost,
Paul L Bellamy,
Prabhu P Raju,
Russell J Glapion,
Saleem A Akhtar,
Samuel Mindaye,
Tamil Arasu, PhD,
Thuy T Nguyen, LCDR,
Wayne E Seifert,
Yongmin Liu,
Yvesna C Blaise,
Zhihao Qiu (Peter), PhD
Yan Wang's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2018 | FDA 483 Response | ImClone Systems LLC - Form 483R, 2018-03-27 |
October, 2022 | FDA 483 | Lupin Limited (Biotech Division) - Form 483, 2022-10-14 |
March, 2018 | FDA 483 | ImClone Systems LLC - Form 483, 2018-03-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more